Literature DB >> 16946700

EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

Mrinal Samanta1, Dai Iwakiri, Teru Kanda, Tadaatsu Imaizumi, Kenzo Takada.   

Abstract

Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) are nonpolyadenylated, untranslated RNAs, exist most abundantly in latently EBV-infected cells, and are expected to show secondary structures with many short stem-loops. Retinoic acid-inducible gene I (RIG-I) is a cytosolic protein that detects viral double-stranded RNA (dsRNA) inside the cell and initiates signaling pathways leading to the induction of protective cellular genes, including type I interferons (IFNs). We investigated whether EBERs were recognized by RIG-I as dsRNA. Transfection of RIG-I plasmid induced IFNs and IFN-stimulated genes (ISGs) in EBV-positive Burkitt's lymphoma (BL) cells, but not in their EBV-negative counterparts or EBER-knockout EBV-infected BL cells. Transfection of EBER plasmid or in vitro-synthesized EBERs induced expression of type I IFNs and ISGs in RIG-I-expressing, EBV-negative BL cells, but not in RIG-I-minus counterparts. EBERs activated RIG-I's substrates, NF-kappaB and IFN regulatory factor 3, which were necessary for type I IFN activation. It was also shown that EBERs co-precipitated with RIG-I. These results indicate that EBERs are recognized by RIG-I and activate signaling to induce type I IFN in EBV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946700      PMCID: PMC1570431          DOI: 10.1038/sj.emboj.7601314

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

Review 1.  Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity.

Authors:  David E Levy; Isabelle Marié; Arun Prakash
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

2.  Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.

Authors:  J Komano; S Maruo; K Kurozumi; T Oda; K Takada
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.

Authors:  Asuka Nanbo; Hironori Yoshiyama; Kenzo Takada
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.

Authors:  N Kitagawa; M Goto; K Kurozumi; S Maruo; M Fukayama; T Naoe; M Yasukawa; K Hino; T Suzuki; S Todo; K Takada
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

5.  Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.

Authors:  Asuka Nanbo; Kaori Inoue; Kumi Adachi-Takasawa; Kenzo Takada
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

6.  Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs.

Authors:  N Yamamoto; T Takizawa; Y Iwanaga; N Shimizu; N Yamamoto
Journal:  FEBS Lett       Date:  2000-11-03       Impact factor: 4.124

7.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

8.  Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation.

Authors:  Mitsuaki Mori; Mitsutoshi Yoneyama; Takashi Ito; Kiyohiro Takahashi; Fuyuhiko Inagaki; Takashi Fujita
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

9.  Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA.

Authors:  Dai Iwakiri; Yoshito Eizuru; Masayoshi Tokunaga; Kenzo Takada
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

10.  Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-gamma.

Authors:  Tadaatsu Imaizumi; Norito Yagihashi; Masaharu Hatakeyama; Koji Yamashita; Akira Ishikawa; Kageaki Taima; Hidemi Yoshida; Ituro Inoue; Takashi Fujita; Soroku Yagihashi; Kei Satoh
Journal:  Life Sci       Date:  2004-07-23       Impact factor: 5.037

View more
  142 in total

Review 1.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

2.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

3.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 4.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 5.  Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.

Authors:  A G Bowie
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 6.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

7.  Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Authors:  Luc Friboulet; Catherine Pioche-Durieu; Sandrine Rodriguez; Alexander Valent; Sylvie Souquère; Hugues Ripoche; Abdelmajid Khabir; Sai Wah Tsao; Jacques Bosq; Kwok Wai Lo; Pierre Busson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Authors:  Stefanie Iskra; Markus Kalla; Henri-Jacques Delecluse; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 9.  Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis.

Authors:  Whitney L Bullard; Erik K Flemington; Rolf Renne; Scott A Tibbetts
Journal:  Trends Cancer       Date:  2018-10-10

10.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.

Authors:  Andrea Ablasser; Franz Bauernfeind; Gunther Hartmann; Eicke Latz; Katherine A Fitzgerald; Veit Hornung
Journal:  Nat Immunol       Date:  2009-07-16       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.